The overarching goal of this study is to determine if S. aureus immunomodulation could be combated with therapeutic modification of CXCR2 activity, as this may lead to the identification of a novel therapeutic strategy to combat biofilm-mediated infections. The gene discussed is CXCR2; the disease is infection.